ASH is urging federal agencies to coordinate hematology funding in order to produce the greatest impact on specific high-need areas. The newly released ASH Agenda for Hematology Research: 2012-2014* is a third update of a strategic plan the Society releases every three years. The latest update describes the many contributions of hematologists both to their own field and to other fields of medicine and articulates the necessity of placing hematology among the top priorities for funding within the healthcare community, both today and in the future.
The ASH Agenda for Hematology Research: 2012-2014 was developed by the ASH Committee on Scientific Affairs with extensive input from all members of the Society’s 17 scientific committees and the Executive Committee. The Agenda consists of two parts. The first section uses stories of success in treating hematologic diseases to illustrate, in human terms, the return on investment of past research support. The second part outlines the foremost challenges confronting the field and identifies the highest priority scientific themes. This section focuses on areas of investigation considered to be the most promising and exciting in the field, including stem cell biology and regenerative medicine, myelodysplastic syndrome and acute myeloid leukemia in the elderly, hematopoietic stem cell transplantation and management of graft-versus-host disease, sickle cell disease, deep-vein thrombosis and venous thromboembolism, and childhood leukemia.
The ASH Agenda for Hematology Research: 2012-2014 is a valuable tool for promoting hematology research to the scientific community, funding agencies, political and legislative bodies, philanthropic organizations, patients and their advocacy groups, and the American public.
Download a two-page summary of key points from the ASH Agenda for Hematology Research: 2012-2014
Read the press release about the ASH Agenda for Hematology Research: 2012-2014
If you have any additional questions and/or comments about the ASH Agenda for Hematology Research, please contact ASH Senior Manager of Scientific Affairs, Ulyana Desiderio, PhD, at 202-776-0544 or email@example.com.
*If you are unable to open this document, please verify that you have the latest version of Adobe Acrobat reader installed on your computer. If you have the latest version of Adobe Acrobat reader installed on your computer and still cannot download this document, please contact firstname.lastname@example.org for assistance.